- Home
- CATO vs VNRX Comparison
CATO vs VNRX Comparison
Compare CATO & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CATO | VNRX |
|---|---|---|
| Founded | 1946 | N/A |
| Country | United States | United States |
| Employees | 7000 | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.0M | 31.9M |
| IPO Year | 1994 | 2012 |
Fundamental Metrics
Financial Performance| Metric | CATO | VNRX |
|---|---|---|
| Price | $3.00 | $0.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 49.1K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.09 | ★ 38.00 |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $649,806,000.00 | $1,233,511.00 |
| Revenue This Year | N/A | $68.22 |
| Revenue Next Year | N/A | $382.75 |
| P/E Ratio | $12.16 | ★ N/A |
| Revenue Growth | N/A | ★ 59.10 |
| 52 Week Low | $2.19 | $0.17 |
| 52 Week High | $4.92 | $0.94 |
Technical Indicators
Market Signals| Indicator | CATO | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.19 | 36.92 |
| Support Level | $2.81 | $0.17 |
| Resistance Level | $3.22 | $0.27 |
| Average True Range (ATR) | 0.18 | 0.02 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 17.31 | 17.93 |
Price Performance
Historical ComparisonAbout CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.